Hamilton Lane (NASDAQ:HLNE) Price Target Raised to $185.00

Hamilton Lane (NASDAQ:HLNE) had its target price hoisted by stock analysts at UBS Group from $150.00 to $185.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the stock. UBS Group’s target price would indicate a potential upside of 4.20% from the stock’s current price.

Several other analysts also recently weighed in on HLNE. Morgan Stanley raised their target price on Hamilton Lane from $140.00 to $182.00 and gave the company an “equal weight” rating in a research note on Thursday, October 10th. JPMorgan Chase & Co. raised their price objective on Hamilton Lane from $120.00 to $134.00 and gave the company a “neutral” rating in a research note on Wednesday, August 7th. The Goldman Sachs Group upped their target price on Hamilton Lane from $139.00 to $147.00 and gave the company a “neutral” rating in a research report on Thursday, October 3rd. Wells Fargo & Company raised their price target on shares of Hamilton Lane from $156.00 to $170.00 and gave the stock an “equal weight” rating in a research report on Wednesday, October 9th. Finally, Keefe, Bruyette & Woods upped their price target on shares of Hamilton Lane from $135.00 to $145.00 and gave the company a “market perform” rating in a report on Wednesday, August 7th. Seven research analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $160.50.

Hamilton Lane Stock Down 0.9 %

NASDAQ HLNE traded down $1.59 on Tuesday, reaching $177.54. The company had a trading volume of 9,260 shares, compared to its average volume of 311,698. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.72 and a quick ratio of 2.72. Hamilton Lane has a 1 year low of $78.66 and a 1 year high of $181.96. The firm has a 50-day moving average of $159.30 and a 200-day moving average of $136.11. The firm has a market capitalization of $9.59 billion, a PE ratio of 48.11 and a beta of 1.19.

Hamilton Lane (NASDAQ:HLNE) last announced its earnings results on Tuesday, August 6th. The company reported $1.51 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.41. The business had revenue of $196.73 million during the quarter, compared to the consensus estimate of $149.84 million. Hamilton Lane had a net margin of 26.99% and a return on equity of 34.36%. During the same period in the prior year, the firm earned $0.94 earnings per share. On average, equities research analysts anticipate that Hamilton Lane will post 4.88 EPS for the current fiscal year.

Institutional Trading of Hamilton Lane

Several institutional investors have recently added to or reduced their stakes in the business. Sierra Capital LLC lifted its position in shares of Hamilton Lane by 141.6% in the 3rd quarter. Sierra Capital LLC now owns 22,718 shares of the company’s stock worth $3,825,000 after buying an additional 13,316 shares during the last quarter. Copeland Capital Management LLC lifted its holdings in Hamilton Lane by 0.8% in the third quarter. Copeland Capital Management LLC now owns 863,397 shares of the company’s stock worth $145,388,000 after acquiring an additional 7,106 shares during the last quarter. Allspring Global Investments Holdings LLC acquired a new position in Hamilton Lane in the third quarter valued at approximately $9,587,000. Creative Planning grew its holdings in shares of Hamilton Lane by 6.1% during the third quarter. Creative Planning now owns 66,601 shares of the company’s stock valued at $11,215,000 after purchasing an additional 3,829 shares during the last quarter. Finally, CWM LLC raised its position in shares of Hamilton Lane by 24.7% during the 3rd quarter. CWM LLC now owns 505 shares of the company’s stock worth $85,000 after purchasing an additional 100 shares during the period. Institutional investors own 97.40% of the company’s stock.

About Hamilton Lane

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.